RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients
Clinical trial NCT03520946 · COMPLETED
Trial details
- NCT number
- NCT03520946
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2024-07-30
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.